新日本製薬

4931JPPrimeMaterials & Chemicals

新日本製薬

Revenue

¥41bn

YoY +2.7%

Operating income

¥5bn

FY2025

Employees

316

Founded

—

Source: EDINET website (https://disclosure.edinet-fsa.go.jp/) — edited by PollNow